CVE-2026-92933vm2 before 3.11.8 Information Disclosure via util.getCallSites
Updated under an hour ago ()
Does this affect you?
It affects patriksimek vm2. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
vm2 is a sandbox for running untrusted Node.js code. In versions <= 3.11.7, NodeVM exposes the host `util` module to the sandbox as an unfiltered shallow copy (`Object.assign({}, util)` in `defaultBuiltinLoaderUtil`), and the deprecated `sys` builtin (an alias of host `util`) is exposed through the generic builtin loader. On Node.js >= 22.9 this hands sandboxed code `util.getCallSites()`, a programmatic stack-introspection API that returns the host process's full call stack, including absolute file paths, function names, and line numbers for vm2 bridge internals and the embedding application's entrypoint. This bypasses the host-frame redaction introduced for GHSA-v27g-jcqj-v8rw, which only applies to the `Error.prepareStackTrace` formatting channel. The issue is fixed in vm2 3.11.8.
- CVSS
- 5.8 MEDIUM (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:L/I:N/A:N
- Weakness (CWE)
- CWE-200
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- VulnCheck
- NVD analysis
- Deferred
- Record last updated
- Sep 19, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
patriksimek vm2 patriksimek:vm2 (from the name) | before 3.11.8; 3.11.8 not affected | CNA record |
References
- https://github.com/patriksimek/vm2/security/advisories/GHSA-r273-hxvj-fxhpvendor-advisory
- https://www.vulncheck.com/advisories/vm2-before-3.11.8-information-disclosure-via-util-getcallsitesthird-party-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.